175 related articles for article (PubMed ID: 23890137)
1. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin.
Wei W; Li H; Li N; Sun H; Li Q; Shen X
Pancreatology; 2013; 13(4):384-92. PubMed ID: 23890137
[TBL] [Abstract][Full Text] [Related]
2. The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma.
Lu W; Wei W; de Bock GH; Zhou H; Li Q; Shen X
Int J Clin Oncol; 2014 Dec; 19(6):1011-9. PubMed ID: 24395444
[TBL] [Abstract][Full Text] [Related]
3. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
Ripka S; König A; Buchholz M; Wagner M; Sipos B; Klöppel G; Downward J; Gress T; Michl P
Carcinogenesis; 2007 Jun; 28(6):1178-87. PubMed ID: 17227781
[TBL] [Abstract][Full Text] [Related]
4. C-Jun N-terminal kinase (JNK) mediates Wnt5a-induced cell motility dependent or independent of RhoA pathway in human dental papilla cells.
Wang C; Zhao Y; Su Y; Li R; Lin Y; Zhou X; Ye L
PLoS One; 2013; 8(7):e69440. PubMed ID: 23844260
[TBL] [Abstract][Full Text] [Related]
5. JNK phosphorylates paxillin and regulates cell migration.
Huang C; Rajfur Z; Borchers C; Schaller MD; Jacobson K
Nature; 2003 Jul; 424(6945):219-23. PubMed ID: 12853963
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
Bo H; Gao L; Chen Y; Zhang J; Zhu M
Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
8. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
9. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
[TBL] [Abstract][Full Text] [Related]
10. High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration.
McCall KD; Harii N; Lewis CJ; Malgor R; Kim WB; Saji M; Kohn AD; Moon RT; Kohn LD
Endocrinology; 2007 Sep; 148(9):4226-37. PubMed ID: 17525119
[TBL] [Abstract][Full Text] [Related]
11. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
13. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.
Qin L; Yin YT; Zheng FJ; Peng LX; Yang CF; Bao YN; Liang YY; Li XJ; Xiang YQ; Sun R; Li AH; Zou RH; Pei XQ; Huang BJ; Kang TB; Liao DF; Zeng YX; Williams BO; Qian CN
Oncotarget; 2015 Apr; 6(12):10239-52. PubMed ID: 25823923
[TBL] [Abstract][Full Text] [Related]
14. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L
Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663
[TBL] [Abstract][Full Text] [Related]
15. JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin.
Huang Z; Yan DP; Ge BX
Cell Signal; 2008 Nov; 20(11):2002-12. PubMed ID: 18713649
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.
Jin Z; Zhao C; Han X; Han Y
BMC Cancer; 2012 Oct; 12():480. PubMed ID: 23075330
[TBL] [Abstract][Full Text] [Related]
18. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
19. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion.
Kurayoshi M; Oue N; Yamamoto H; Kishida M; Inoue A; Asahara T; Yasui W; Kikuchi A
Cancer Res; 2006 Nov; 66(21):10439-48. PubMed ID: 17079465
[TBL] [Abstract][Full Text] [Related]
20. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V
Gynecol Oncol; 2014 Aug; 134(2):338-45. PubMed ID: 24924122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
